Teva charts 300-plus layoffs at troubled California injectables plant
Teva Parenteral Medicines, Inc. - Form 483, 2003-08-29 - Redica Systems Store
Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) Due to Particulate Matter | Business Wire
UPDATE 2-Teva halts output at U.S. drug plant after FDA flags concerns